European Union | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
European Union
Records
63
Source
European Union | Immunization, measles (% of children ages 12-23 months)
year value
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 27.72601521
1981 35.32897978
1982 37.51646002
1983 47.53945092
1984 55.0251951
1985 59.76524884
1986 63.53945936
1987 67.84685343
1988 68.62665636
1989 71.86483128
1990 79.36752898
1991 79.15347026
1992 79.9633826
1993 81.90770369
1994 83.89777296
1995 85.06905568
1996 86.72220805
1997 86.99138115
1998 86.67918394
1999 88.49947732
2000 89.16338479
2001 90.29559638
2002 91.28086035
2003 92.25468661
2004 92.69706794
2005 92.84977807
2006 93.68683057
2007 94.24957321
2008 94.26587265
2009 94.19181327
2010 94.0745836
2011 94.14402085
2012 94.65472252
2013 94.28408304
2014 93.95048338
2015 93.47509215
2016 93.52944528
2017 94.11244931
2018 94.29360603
2019 94.71257609
2020 93.23699588
2021 92.52686005
2022 91.93798601

European Union | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
European Union
Records
63
Source